Objectives

After participating in this educational activity, attendees should be able to:
1. Introduce new organizational framework and access to Covid-19 clinical practice guidelines
2. Discuss the approach to risk-stratification of the patient with Covid-19 in our Baystate Emergency Departments
3. Review key recent updates in the treatment and processes of care of hospitalized patients with Covid-19, focusing on respiratory support, VTE prophylaxis, antiviral and immunomodulatory treatment, and discharge planning
4. Review important principles of outpatient care including use of monoclonal antibodies

Faculty

Speaker Name
Amanda Westlake, MD
Division of Infectious Diseases
Division of General Medicine and Community Health
Assistant Professor, UMMS - Baystate

Benjamin Freda, DO
Division of Hospital Medicine
Baystate Medical Center

Tala Elia, MD
Department of Emergency Medicine
Associate Professor, UMMS - Baystate

 

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.

None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.      

                                                        

Session date: 
Wednesday, October 6, 2021 - 8:00am to 9:00am
Location: 
Webinar Live
MA
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.